MassBio: What Constitutes Great Companies and Boards? Views from Two Life Science Leaders

Download IconDownload Print IconPrint

MassBio: What Constitutes Great Companies and Boards? Views from Two Life Science Leaders

Cambridge, MA
Speaking Engagement
What constitutes great companies and boards? This program will feature Jean George, general partner of Advanced Technology (ATV) and Lightstone Ventures, an investor who focuses on life science companies and Marsha Fanucci, former chief financial officer and SVP of Millennium Pharmaceuticals who now serves as a board member for multiple biotechnology companies, including Alnylam, Forma, Ironwood and Momenta. The fireside chat will focus on Jean and Marsha's career trajectories and their observations and learnings from working as board members with management teams. The discussion will include: how great companies are identified, key elements an investor seeks in a start-up, what are best practices by management teams in working with their board, how to be an excellent board member and the key skills required for being an outstanding investor and board member. This robust and interactive conversation will be an opportunity to hear and ask about the realities of working with venture capital firms and boards.

Read More About the Event

You May Be Interested In

FIA Law & Compliance Division Conference 2024

April 24–26, 2024
Speaking Engagement

18th Annual Flagship Conference on Economic Sanctions Enforcement and Compliance

April 29, 2024
Speaking Engagement

Essentials of the European Union’s Artificial Intelligence Act

May 2, 2024
Webinar
View all Events

Notice

Unless you are an existing client, before communicating with WilmerHale by e-mail (or otherwise), please read the Disclaimer referenced by this link.(The Disclaimer is also accessible from the opening of this website). As noted therein, until you have received from us a written statement that we represent you in a particular manner (an "engagement letter") you should not send to us any confidential information about any such matter. After we have undertaken representation of you concerning a matter, you will be our client, and we may thereafter exchange confidential information freely.

Thank you for your interest in WilmerHale.

I Accept Cancel